Precision Optics (POCI) Lytham Partners 2026 Consumer & Technology Investor Summit summary
Event summary combining transcript, slides, and related documents.
Lytham Partners 2026 Consumer & Technology Investor Summit summary
18 Aug, 2026Business overview and core capabilities
Specializes in micro-optics, ultra-high precision systems, and digital imaging for medical, defense, and aerospace markets.
Manufactures some of the smallest optics globally, enabling advanced endoscopy and satellite communications.
Offers end-to-end solutions from design to mass manufacturing, leveraging proprietary technology.
Application-agnostic technology serves both medical and aerospace sectors, with a history rooted in medical devices.
Recent growth driven by two major programs in satellite communication and single-use endoscopy.
Satellite communications market
Industry shift toward laser-based satellite communication for higher bandwidth and standardized protocols.
Supplies precision components for Optical Communication Terminals, critical for satellite-to-satellite links.
Achieves sub-5 micron alignment for space-ready optical assemblies, supporting durability and performance.
Sole-source supplier for a major customer, with ongoing and future opportunities as satellite networks expand.
Recurring revenue expected as satellites require replacement every 3–5 years due to orbital decay.
Defense sector opportunities
Holds a major defense contract and sees potential in laser weapons and drone optics.
Defense spending is rising, with a trend toward longer-term contracts that align with the business model.
Proactive approach to expanding presence in defense, targeting additional programs.
Latest events from Precision Optics
- Production ramp in medical and satellite optics drives revenue growth and margin recovery.POCI
Planet MicroCap Las Vegas 2026 - Accelerated revenue growth driven by new production programs and robust technology pipeline.POCI
Lytham Partners Spring 2026 Investor Conference - Strong revenue growth, major new orders, and expanding product pipeline drive future prospects.POCI
Corporate presentation - Record Q3 revenue, margin gains, and a $10M+ offering drove raised FY2026 guidance.POCI
Q3 2026 - Strong revenue growth and major orders fuel expansion in medical and defense optics.POCI
Investor presentation - Record revenue growth offset by margin compression and liquidity risks.POCI
Q2 2026 - Shareholders will vote on director elections, executive pay, and auditor ratification at the 2025 meeting.POCI
Proxy Filing - Votes will be cast on director elections, executive pay, and auditor ratification at the 2026 meeting.POCI
Proxy Filing - Revenue and margins fell, but backlog and new contracts support a strong Q4 outlook.POCI
Q3 2025